Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI)

National Cancer Institute (NCI) seeks to obtain OMB approval to extend the generic clearance to collect qualitative feedback on our service delivery for an additional three years. This information collection activity has garnered qualitative customer and stakeholder feedback efficient, timely manner, to the Administration’s commitment to improving service delivery. This generic has provided information about the National Cancer Institute’s customer or stakeholder perceptions, experiences, and expectations, provided an early warning of service issues or focused attention on areas where communication, training, or operations changes might improve product or service delivery. It has also allowed feedback to contribute directly to the improvement of program management. Feedback collected under this generic clearance provides helpful information but does not yield data that can be generalized to the overall population.

The latest form for Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NCI) expires 2026-04-30 and can be found here.